SCHEMBL6229448

SCHEMBL6229448

CC1(O)CCCC1(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28004189 0.79
SCHEMBL1822588 0.73
SCHEMBL29015342 0.73
SCHEMBL25842994 0.73
SCHEMBL4398631 0.72
SCHEMBL3873177 0.70
Hydrochloric Acid SCHEMBL23536142 0.70
SCHEMBL5181216 0.67
SCHEMBL8899108 0.67
SCHEMBL10358961 0.66 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515971-A2 CARBOCYCLIC NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE Merck & Co., Inc. (US) 2005-03-23 EP disclosed
WO-2003106477-A1 OLIGOMERIC COMPOUNDS THAT INCLUDE CARBOCYCLIC NUCLEOSIDES AND THEIR USE IN GENE MODULATION ISIS PHARMACEUTICALS, INC. (US) 2003-12-24 WO disclosed
WO-2003105770-A2 CARBOCYCLIC NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE MERCK & CO., INC. (US) 2003-12-24 WO disclosed